CClinicalTrials.gg
RecruitingNCT06792773Updated Feb 4, 2026

2024 NewAnescat Register

An observational study in Anesthesia, sponsored by Consorci Sanitari de Terrassa. Recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Consorci Sanitari de Terrassa · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
13,634
Sex
All
01

Study summary

20 years ago, for the first time in Spain, a record was made of all the activity carried out by a medical speciality, called ANESCAT 2003. After 20 years, the increase in healthcare activity has exceeded the expectations and predictions that were made at the time. Therefore, it is necessary to make a new assessment of the work situation in which our speciality finds itself in order to be able to evaluate whether the increase in resources allocated has been proportional and therefore to be able to have objective data with a view to making new demands and planning future needs.

02

Conditions studied

  • Anesthesia
03

In context

Lead sponsor

Consorci Sanitari de Terrassa is the lead sponsor of 41 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population is all patients involving anaesthetic activity during the study days (14 days in a year).

Eligibility criteria

The activity of all the areas in which the anaesthesiologist has some kind of work involvement over 24 hours during 14 days in a year is included through several questionnaires with different formats. Therefore all patients will be included without restriction criteria.

05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
13,634 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Anaesthesia surgical activity

    The main outcome and objective of the study is to quantify all the anaesthesia activity

    Time frame: Assessed during the 14-day cut-off period of the study over one year

  2. Anaesthesia activity in the Intensive Care Units

    The main outcome and objective of the study is to quantify all the anaesthesia activity

    Time frame: Assessed during the 14-day cut-off period of the study over one year

  3. Anaesthesia activity in the Chronic Pain Units

    The main outcome and objective of the study is to quantify all the anaesthesia activity

    Time frame: Assessed during the 14-day cut-off period of the study over one year

  4. Anaesthesia activity in the delivery rooms

    The main outcome and objective of the study is to quantify all the anaesthesia activity

    Time frame: Assessed during the 14-day cut-off period of the study over one year

Secondary outcomes

  1. Percentage of active staff in anaesthesiology services

    With the aim of finding out the real needs of professionals in relation to medical activity

    Time frame: Assessed during the 14-day cut-off period of the study over one year

  2. The role of anaesthesiology services in Catalonia with regard to polytrauma patients

    The role of anaesthesiology services in Catalonia with regard to polytrauma patients

    Time frame: Assessed during the 14-day cut-off period of the study over one year

  3. The role of anaesthesiology services in Catalonia with regard to cardiorespiratory arrest

    The role of anaesthesiology services in Catalonia with regard to cardiorespiratory arrest

    Time frame: Assessed during the 14-day cut-off period of the study over one year

07

Study locations

1 of 1 sites recruiting
  • Hospital Clinic de Barcelona
    Barcelona, Barcelona 08036, Spain
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06792773
Lead sponsor
Consorci Sanitari de Terrassa
Responsible party
Carles Espinos Ramírez (Medical Doctor, Germans Trias i Pujol Hospital) — Principal investigator
First posted
Jan 27, 2025
Start date
May 4, 2025
Primary completion
May 2026 (estimated)
Completion
May 2026 (estimated)
Last update
Feb 4, 2026

Study contacts

Carles Espinós, MD
Contact
md071683@uic.es
650125113 ext. 0034
Carles Espinós, MD
principal investigator · Germans Trias i Pujol Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion